Pregabalin | C8H17NO2 | CID 5486971

Pregabalin, which is chemically represented as C8H17NO2, is an analogue of the neurotransmitter gamma-aminobutyric acid (GABA). This drug exhibits both analgesic and anticonvulsant properties, making it a significant player in the management of neuropathic pain and partial seizures.

Pregabalin's Mechanism of Action

Pregabalin works by binding to an auxiliary subunit (α2-δ protein) of voltage-gated calcium channels in the central nervous system. This binding inhibits the release of several neurotransmitters, such as glutamate, noradrenaline, and substance P, which are crucial in the pathways of pain and seizure disorders. Notably, it does not interact with GABA receptors nor is it transformed metabolically into GABA.

Clinical Efficacy in Neuropathic Pain

Clinical trials have shown that pregabalin effectively reduces pain in conditions such as diabetic peripheral neuropathy and post-herpetic neuralgia. In double-blind, placebo-controlled studies, a significant proportion of patients treated with 300 or 600 mg/day reported substantial improvements in pain, with many experiencing relief as early as one week into treatment.

Use in Epilepsy

When used as an adjunct therapy for adults with partial seizures, pregabalin has demonstrated efficacy in reducing the frequency of seizures. Clinical studies indicated that the optimal dosing regimen could reach up to 600 mg/day, tailored based on individual response and tolerance.

Pharmacokinetics of Pregabalin

Pregabalin is rapidly absorbed with a bioavailability close to 90%. The drug’s pharmacokinetics show linear characteristics over a broad dosing range. Peak plasma concentrations occur within one hour, and it is predominantly excreted unchanged in the urine.

Special Populations Considerations

In patients with compromised renal function, dosing of pregabalin needs to be appropriately adjusted. There is no requirement for dose adjustments in patients with hepatic impairment; however, it is essential to consider individual patient factors.

Adverse Effects and Warnings

Common side effects associated with pregabalin include dizziness, somnolence, and weight gain, with a noted potential risk for suicidal ideation, which necessitates careful monitoring during treatment. Patients are advised against operating heavy machinery or driving until they are fully aware of how the medication affects them.

Furthermore, pregabalin should be discontinued gradually to minimize the risk of withdrawal symptoms, particularly in patients receiving high doses. Caution is warranted when combining pregabalin with other CNS depressants, given the increased risk of severe respiratory depression.

For additional information on Pregabalin or to explore other pharmaceutical options, please see our respected sources.

For further inquiries regarding the chemical composition or use of cas -80-4, please reach out to our knowledgeable staff.

Our company also caters to your needs for other products, such as -31-2, providing you with comprehensive support for all your pharmaceutical requirements.